NDC product
Sildenafil
NDC 68001-363 · BluePoint Laboratories
Key facts
| Product NDC | 68001-363 |
|---|---|
| Proprietary name | Sildenafil |
| Nonproprietary name | Sildenafil |
| Substances | SILDENAFIL CITRATE |
| Dosage form | TABLET, FILM COATED |
| Route | ORAL |
| Labeler | BluePoint Laboratories |
| Product type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Application number | ANDA203814 |
| Pharmacologic classes | Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA] |
| Marketing start | Sep 14, 2018 |
| Marketing end | Oct 31, 2027 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory